Purinergic receptors in the nervous system

被引:32
作者
Burnstock, G [1 ]
机构
[1] Royal Free & UCL, Sch Med, Auton Neurosci Inst, London NW3 2PF, England
来源
EXTRACELLULAR NUCLEOTIDES AND NUCLEOSIDES: RELEASE, RECEPTORS, AND PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS | 2003年 / 54卷
关键词
D O I
10.1016/S1063-5823(03)01010-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:307 / 368
页数:62
相关论文
共 531 条
  • [1] Abbracchio Maria P., 1997, P383
  • [2] Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative disease
    Abbracchio, MP
    Cattabeni, F
    [J]. NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE, 1999, 890 : 79 - 92
  • [3] PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS
    ABBRACCHIO, MP
    BURNSTOCK, G
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) : 445 - 475
  • [4] Purinergic signalling: Pathophysiological roles
    Abbracchio, MP
    Burnstock, G
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (02) : 113 - 145
  • [5] ATP RESPONSES IN THE EMBRYO CHICK CILIARY GANGLION-CELLS
    ABE, Y
    SORIMACHI, M
    ITOYAMA, Y
    FURUKAWA, K
    AKAIKE, N
    [J]. NEUROSCIENCE, 1995, 64 (02) : 547 - 551
  • [6] AGREN H, 1983, PSYCHIAT RES, V9, P179
  • [7] MODULATORY ACTIONS OF ATP ON MEMBRANE-POTENTIALS OF BULLFROG SYMPATHETIC-GANGLION CELLS
    AKASU, T
    HIRAI, K
    KOKETSU, K
    [J]. BRAIN RESEARCH, 1983, 258 (02) : 313 - 317
  • [8] Immunohistochemical evidence for ATP receptors in human dental pulp
    Alavi, AM
    Dubyak, GR
    Burnstock, G
    [J]. JOURNAL OF DENTAL RESEARCH, 2001, 80 (02) : 476 - 483
  • [9] THE ACTIONS OF ADENOSINE 5'-TRIPHOSPHATE ON GUINEA-PIG INTRACARDIAC NEURONS IN CULTURE
    ALLEN, TGJ
    BURNSTOCK, G
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (02) : 269 - 276
  • [10] P2 receptor modulation and cytotoxic function in cultured CNS neurons
    Amadio, S
    D'Ambrosi, N
    Cavaliere, F
    Murra, B
    Sancesario, G
    Bernardi, G
    Burnstock, G
    Volonté, C
    [J]. NEUROPHARMACOLOGY, 2002, 42 (04) : 489 - 501